Immediate Impact
34 standout
Citing Papers
The AUA/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder
2024 Standout
Summary Paper on the 2023 European Association of Urology Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms
2023 Standout
Works of David Mitcheson being referenced
Urodynamics and Safety of the β 3 -Adrenoceptor Agonist Mirabegron in Males with Lower Urinary Tract Symptoms and Bladder Outlet Obstruction
2013
Randomized Double-blind, Active-controlled Phase 3 Study to Assess 12-Month Safety and Efficacy of Mirabegron, a β3-Adrenoceptor Agonist, in Overactive Bladder
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| David Mitcheson | 591 | 457 | 355 | 10 | 646 | |
| Peter J. Boerrigter | 464 | 333 | 281 | 12 | 636 | |
| Gerhard Compion | 445 | 381 | 261 | 15 | 579 | |
| Joseph T. Wang | 683 | 550 | 324 | 22 | 735 | |
| Vasudha Vats | 522 | 497 | 267 | 9 | 608 | |
| K. E. Whitmore | 586 | 457 | 273 | 7 | 737 | |
| H. Kurth | 432 | 448 | 288 | 7 | 600 | |
| Alexander Gomelsky | 431 | 508 | 195 | 12 | 605 | |
| H.J. Rollema | 657 | 478 | 132 | 13 | 706 | |
| T.B. Madden | 436 | 553 | 165 | 12 | 673 | |
| Gerd Mürtz | 526 | 441 | 275 | 22 | 565 |
All Works
Loading papers...